A randomized phase II trial of short-course androgen deprivation therapy with or without bevacizumab for patients with recurrent prostate cancer after definitive local therapy

Rana R. McKay, Amado J. Zurita, Lillian Werner, Justine Y. Bruce, Michael A. Carducci, Mark N. Stein, Elisabeth I. Heath, Arif Hussain, Hai T. Tran, Christopher J. Sweeney, Robert W. Ross, Philip W. Kantoff, Susan F. Slovin, Mary Ellen Taplin

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A randomized phase II trial of short-course androgen deprivation therapy with or without bevacizumab for patients with recurrent prostate cancer after definitive local therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences